Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Brain Glioblastoma
and you are
over 19
years old
0
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

This early phase I trial studies the how well fluorodeoxyglucose F-18 (FDG) positron emission tomography (PET) imaging works in diagnosing patients with confirmed or suspected glioblastoma. Diagnostic procedures, such as FDG PET, may help find and diagnose glioblastoma.

Provided treatments

  • Procedure: Computed Tomography
  • Radiation: Fludeoxyglucose F-18
  • Procedure: Magnetic Resonance Imaging
  • Procedure: Positron Emission Tomography
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02885272. The sponsor of the trial is M.D. Anderson Cancer Center and it is looking for 20 volunteers for the current phase.
Official trial title:
Dual Time Point FDG PET Imaging Optimization for the Evaluation of Glioblastoma